Outcome after combined modality treatment for uterine papillary serous carcinoma: A study by the Rare Cancer Network (RCN)

Goldberg, Hadassah; Miller, Robert; Abdah-Bortnyak, Roxolyana; Steiner, Mariana; YILDIZ, FERAH; Meirovitz, Amichav; Villa, Salvador; Poortmans, Philip; Azria, David; Zidan, Jamal; Ozsahin, Mahmut; Abacioglu, MEHMET; Gold, Douglas; Amit, Amnon; Lavie, Ofer; Atahan, I.; Kuten, Abraham

doi:10.1016/j.ygyno.2007.10.037

Outcome after combined modality treatment for uterine papillary serous carcinoma: A study by the Rare Cancer Network (RCN)

Goldberg H., Miller R. C., Abdah-Bortnyak R., Steiner M., YILDIZ F., Meirovitz A., ...Daha Fazla

GYNECOLOGIC ONCOLOGY, cilt.108, sa.2, ss.298-305, 2008 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 108 Sayı: 2
Basım Tarihi: 2008
Doi Numarası: 10.1016/j.ygyno.2007.10.037
Dergi Adı: GYNECOLOGIC ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.298-305
Anahtar Kelimeler: chemotherapy, radiation therapy, surgery, uterine papillary serous carcinoma, STAGE-I PATIENTS, CHEMOTHERAPY, RADIOTHERAPY, MANAGEMENT, RADIATION, SURVIVAL, ENDOMETRIUM, DOXORUBICIN, CISPLATIN
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Objectives. Uterine papillary serous carcinoma (UPSC) is a rare subtype of endometrial carcinoma, characterized by a poor outcome. We sought to better analyze the effect of surgery and adjuvant therapies on this disease.